Investigation of Interactions Between Faldaprevir, Itraconazole, Atorvastatin and Rosuvastatin in Healthy Male and Female Subjects (Open-label, Fixed-sequence)

Trial Profile

Investigation of Interactions Between Faldaprevir, Itraconazole, Atorvastatin and Rosuvastatin in Healthy Male and Female Subjects (Open-label, Fixed-sequence)

Completed
Phase of Trial: Phase I

Latest Information Update: 05 Aug 2015

At a glance

  • Drugs Atorvastatin (Primary) ; Faldaprevir (Primary) ; Itraconazole (Primary) ; Rosuvastatin (Primary)
  • Indications Acute coronary syndromes; Atherosclerosis; Atrial fibrillation; Cardiovascular disorders; Heart failure; Hepatitis C; Hypercholesterolaemia; Hyperlipidaemia; Hyperlipoproteinaemia type IIa; Hyperlipoproteinaemia type III; Hypertriglyceridaemia; Mycoses; Myocardial infarction; Myocardial ischaemia; Onychomycosis; Retinal vascular occlusion; Stroke; Vulvovaginal candidiasis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 15 May 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 30 Apr 2013 Planned End Date changed from 1 Apr 2013 to 1 May 2013 as reported by ClinicalTrials.gov.
    • 30 Apr 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top